Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Which fluoroquinolone is contraindicated in patients with liver disease?

Pefloxacin. ***Pefloxacin*** - **Pefloxacin** is primarily metabolized by the **liver**, and its accumulation due to hepatic impairment can lead to increased toxicity and adverse effects, making it contraindicated. - Patients with **severe liver disease** are at a higher risk of experiencing elevated drug levels, leading to complications like **tendinopathy**, **CNS side effects**, or **hepatotoxicity**. *Levofloxacin* - **Levofloxacin** is predominantly excreted by the **kidneys** and only minimally metabolized by the liver, making it generally safer in patients with hepatic impairment. - While dose adjustments may be necessary in **renal dysfunction**, liver disease typically does not require significant modifications. *Ofloxacin* - **Ofloxacin** elimination is primarily **renal**, with little hepatic metabolism, thus it is generally considered safe for use in patients with liver disease. - It does not undergo extensive biotransformation in the liver, minimizing the risk of accumulation in individuals with impaired hepatic function. *Lomefloxacin* - **Lomefloxacin** is relatively safe in patients with liver disease as it is predominantly eliminated renally, similar to levofloxacin and ofloxacin. - Its metabolic pathway does not involve significant hepatic processing, reducing the concern for toxicity in individuals with compromised liver function.

Q: A patient presents to the emergency department with a history of ingestion of ten tablets of paracetamol. He has developed oliguria and liver function tests show deranged values. In the context of paracetamol overdose, which of the following can be used in the management of this condition?

N-acetylcysteine. **Correct: N-acetylcysteine** - **N-acetylcysteine (NAC)** is the specific antidote for **paracetamol overdose**, working by replenishing **glutathione** stores in the liver. - Replenishing **glutathione** helps detoxify the toxic metabolite **N-acetyl-p-benzoquinone imine (NAPQI)**, preventing further **hepatic damage** and facilitating recovery in cases of **liver failure** and potential **renal damage** (oliguria). - Most effective when given within **8 hours** of ingestion, but remains beneficial even with **established hepatotoxicity** (as in this case with deranged LFTs). *Incorrect: Dopamine* - **Dopamine** is a **vasopressor** primarily used to increase **blood pressure** and **cardiac output** in conditions like **shock**. - While it might be used to support circulation in severe overdose complications, it does not directly treat the **paracetamol toxicity** itself. *Incorrect: Ursodeoxycholic acid* - **Ursodeoxycholic acid (UDCA)** is a **cholagogue** used in the management of **cholestatic liver diseases** (e.g., primary biliary cholangitis) by improving bile flow. - It has no role in the direct management of **acute liver failure** due to **paracetamol overdose**. *Incorrect: Furosemide* - **Furosemide** is a **loop diuretic** used to increase **urine output** in conditions like **fluid overload** or **heart failure**. - While **oliguria** is present, it is often a sign of **acute kidney injury** requiring supportive care, and furosemide would not address the underlying **toxic mechanism** of paracetamol.

Q: Patient with pulmonary fibrosis. Which antiarrhythmic drug is contraindicated?

Amiodarone. Amiodarone - **Amiodarone** is contraindicated in patients with pulmonary fibrosis due to its well-known and potentially severe pulmonary toxicity, which can exacerbate existing lung conditions or induce new ones like **interstitial lung disease**. Dose-related pulmonary toxicity is the most important adverse effect, and potentially fatal pulmonary fibrosis can be observed even at low doses [1]. - Its long half-life means that its toxic effects, including **pulmonary toxicity**, can persist for an extended period even after discontinuation [1], [2]. *Flecainide* - **Flecainide** is a Class IC antiarrhythmic drug primarily associated with cardiac side effects and is generally not contraindicated in patients with pulmonary fibrosis. - Its main risks include **proarrhythmia**, especially in patients with structural heart disease, but not pulmonary issues [3]. *IV ibutilide* - **IV ibutilide** is a Class III antiarrhythmic agent used for rapid conversion of atrial fibrillation/flutter and is not specifically contraindicated in pulmonary fibrosis. - Its primary concern is the risk of **QT prolongation** and **Torsades de Pointes**, rather than pulmonary complications. *Lidocaine* - **Lidocaine** is a Class IB antiarrhythmic typically used for ventricular arrhythmias, especially in the setting of acute myocardial infarction. It is not contraindicated in pulmonary fibrosis. - Its main side effects are **neurological (e.g., seizures, paresthesias)** at higher doses, not pulmonary complications.

Q: What is the drug of choice for preventing chemotherapy-induced vomiting?

Granisetron. ***Granisetron*** - As a **5-HT3 receptor antagonist**, granisetron is highly effective in blocking serotonin-mediated nausea and vomiting caused by chemotherapy. - It works by blocking serotonin receptors in the **chemoreceptor trigger zone** and the **gastrointestinal tract**, which are key sites for chemotherapy-induced emesis. *Prazosin* - This drug is an **alpha-1 adrenergic blocker** primarily used for hypertension and benign prostatic hypertrophy. - It has no significant antiemetic properties and is not indicated for preventing chemotherapy-induced vomiting. *Clonidine* - **Clonidine** is an **alpha-2 adrenergic agonist** typically used for hypertension, ADHD, and withdrawal syndromes. - It does not act on the pathways responsible for chemotherapy-induced nausea and vomiting. *Dimenhydrinate* - **Dimenhydrinate** is an **antihistamine** with antiemetic properties primarily used for motion sickness and mild nausea. - While it can help with some forms of nausea, it is generally not potent enough to prevent the severe vomiting induced by highly emetogenic chemotherapy.

Q: Which drug decreases the bone resorption in osteoporosis?

Risedronate. ***Risedronate*** - **Risedronate** is a **bisphosphonate**, a class of drugs that inhibits osteoclast activity, thereby decreasing **bone resorption**. - By reducing the rate at which bone is broken down, it helps to preserve **bone mineral density** in patients with osteoporosis. *Teriparatide* - **Teriparatide** is a **parathyroid hormone analog** that primarily works by stimulating **osteoblast activity** to promote new bone formation. - While it treats osteoporosis, its primary mechanism is **anabolic** (bone building), not directly decreasing bone resorption as its main effect. *Cortisone* - **Cortisone** is a **glucocorticoid** that can actually *worsen* osteoporosis by increasing **bone resorption** and decreasing **bone formation** with long-term use. - It is used to treat inflammatory conditions, not to decrease bone resorption for osteoporosis. *Cimetidine* - **Cimetidine** is an **H2-receptor antagonist** used to reduce stomach acid production, commonly for conditions like GERD or ulcers. - It has no known effect on **bone metabolism** or **osteoporosis**.

Q: Which of the following statements about flumazenil is correct?

Can be used in benzodiazepine overdose. ***Can be used in benzodiazepine overdose*** - **Flumazenil** is a **competitive antagonist** at the **GABA-A receptor**, specifically designed to reverse the effects of **benzodiazepines**. - It binds to the same receptor site as benzodiazepines, effectively blocking their sedative and anxiolytic actions, making it useful in emergent overdose situations. *Can be used in barbiturate poisoning* - **Flumazenil** is **ineffective** in **barbiturate overdose** because barbiturates bind to a different site on the GABA-A receptor than benzodiazepines. - Barbiturates enhance **GABAergic activity** through a distinct mechanism, which flumazenil does not antagonize. *Specific antidote for opiate overdose* - The **specific antidote for opiate overdose** is **naloxone**, which acts as an opioid receptor antagonist. - **Flumazenil** has **no affinity** for opioid receptors and thus no role in reversing opiate toxicity. *None of the options* - This option is incorrect because **flumazenil** is indeed used for **benzodiazepine overdose**, as described above. - Its specific mechanism of action targets benzodiazepine-induced central nervous system depression.

Q: Intracranial pressure may be increased by all of the following drugs except -

Aminoglycosides. ***Aminoglycosides*** - **Aminoglycosides** are not typically associated with increasing intracranial pressure. Their primary toxicities include **ototoxicity** and **nephrotoxicity**. - There is no established physiological mechanism by which aminoglycosides directly elevate ICP. *Vitamin A* - **Vitamin A toxicity**, particularly the chronic form of hypervitaminosis A, is a known cause of **idiopathic intracranial hypertension (pseudotumor cerebri)**, which directly increases ICP. - This occurs due to an unknown mechanism that leads to impaired CSF absorption or increased CSF production. *Corticosteroids* - While corticosteroids are often used to reduce cerebral edema and ICP, their **withdrawal**, particularly after prolonged use, can lead to rebound increases in ICP. - In certain susceptible individuals, or with paradoxical reactions, corticosteroids can also induce **pseudotumor cerebri**, leading to elevated ICP. *Quinolones* - **Quinolones** (fluoroquinolones) have been implicated in cases of **drug-induced intracranial hypertension (pseudotumor cerebri)**. - The mechanism is not fully understood but is thought to involve effects on **cerebrospinal fluid dynamics**.

Q: Which of the following drugs can lead to pemphigus?

Penicillamine. ***Penicillamine*** - **Penicillamine** is a well-known drug that can induce **pemphigus**, often through mechanisms involving alterations in **desmosome structure** or function. - The drug's sulfhydryl groups are thought to interfere with the integrity of **desmoglein proteins**, leading to blister formation. *Isoniazid* - **Isoniazid** is a first-line antituberculosis drug primarily associated with **hepatotoxicity** and **peripheral neuropathy**. - It is not typically implicated in the development of **pemphigus**. *Carbamazepine* - **Carbamazepine** is an anticonvulsant that can cause various cutaneous reactions, most notably **Stevens-Johnson syndrome (SJS)** and **toxic epidermal necrolysis (TEN)**. - While it can cause severe skin reactions, **pemphigus** is not a common side effect of carbamazepine. *Furosemide* - **Furosemide** is a loop diuretic that can cause **photosensitivity**, rashes, and rarely, severe skin reactions like **erythema multiforme**. - It is not recognized as a drug that induces **pemphigus**.

Q: Which of the following methods can reduce flushing caused by niacin?

All of the options. ***All of the options*** - **All three methods** (tachyphylaxis, laropiprant, and premedication with aspirin) are effective strategies for reducing niacin-induced flushing. - This demonstrates that multiple pharmacological and physiological approaches can mitigate this common side effect of niacin therapy. **Why each method works:** **Tachyphylaxis:** - Refers to the rapid decrease in response to a drug after repeated administration - With continued niacin use, tolerance develops and flushing intensity decreases over time - This is a natural adaptive response, though not an immediate solution for initial flushing episodes **Laropiprant:** - A selective antagonist of the **prostaglandin D2 receptor 1 (DP1)** - Specifically developed to reduce niacin-induced flushing by blocking prostaglandin D2-mediated vasodilation - Was marketed in combination with niacin (though later withdrawn due to other safety concerns) **Premedication with aspirin:** - **Aspirin** or other NSAIDs taken approximately 30 minutes before niacin administration - Reduces flushing by inhibiting **prostaglandin synthesis**, particularly prostaglandin D2 - Prostaglandins are key mediators of the cutaneous vasodilation that causes flushing

Q: Which vitamin/nutrient toxicity is associated with excessive sweating?

Choline. ***Choline*** - **Excessive sweating** is a recognized symptom of choline toxicity, often accompanied by a **fishy body odor**, hypotension, and gastrointestinal distress. - Choline plays a role in various metabolic pathways, and high doses can overwhelm these systems, leading to adverse effects. *Biotin* - **Biotin toxicity** is extremely rare, even at very high doses; there are no well-documented cases of adverse effects from excessive intake. - Symptoms like excessive sweating are not associated with biotin overdose. *Folic acid* - While high doses of **folic acid** can mask a **vitamin B12 deficiency**, side effects like gastrointestinal upset or sleep disturbances are rare. - Excessive sweating is **not a characteristic symptom** of folic acid toxicity. *Niacin (Vitamin B3)* - High doses of niacin, especially its nicotinic acid form, are well-known to cause **flushing, itching, and liver toxicity**. - While skin effects are common with niacin toxicity, **excessive sweating** as a primary symptom is not typically reported.

Question 1

Which fluoroquinolone is contraindicated in patients with liver disease?

Accepted Answer

Pefloxacin

Answer

Ofloxacin

Answer

Lomefloxacin

Answer

Levofloxacin

Question 2

A patient presents to the emergency department with a history of ingestion of ten tablets of paracetamol. He has developed oliguria and liver function tests show deranged values. In the context of paracetamol overdose, which of the following can be used in the management of this condition?

Accepted Answer

N-acetylcysteine

Answer

Dopamine

Answer

Ursodeoxycholic acid

Answer

Furosemide

Question 3

Patient with pulmonary fibrosis. Which antiarrhythmic drug is contraindicated?

Accepted Answer

Amiodarone

Answer

Flecainide

Answer

Lidocaine

Answer

IV ibutilide

Question 4

What is the drug of choice for preventing chemotherapy-induced vomiting?

Accepted Answer

Granisetron

Answer

Prazosin

Answer

Clonidine

Answer

Dimenhydrinate

Question 5

Which drug decreases the bone resorption in osteoporosis?

Accepted Answer

Risedronate

Answer

Teriparatide

Answer

Cortisone

Answer

Cimetidine

Question 6

Which of the following statements about flumazenil is correct?

Accepted Answer

Can be used in benzodiazepine overdose

Answer

Can be used in barbiturate poisoning

Answer

Specific antidote for opiate overdose

Answer

None of the options

Question 7

Intracranial pressure may be increased by all of the following drugs except -

Accepted Answer

Aminoglycosides

Answer

Quinolones

Answer

Vitamin A

Answer

Corticosteroids

Question 8

Which of the following drugs can lead to pemphigus?

Accepted Answer

Penicillamine

Answer

Carbamazepine

Answer

Isoniazid

Answer

Furosemide

Question 9

Which of the following methods can reduce flushing caused by niacin?

Accepted Answer

All of the options

Answer

Tachyphylaxis

Answer

Laropiprant

Answer

Premedication with aspirin

Question 10

Which vitamin/nutrient toxicity is associated with excessive sweating?

Accepted Answer

Choline

Answer

Biotin

Answer

Folic acid

Answer

Niacin (Vitamin B3)

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?